| Literature DB >> 35324832 |
Janka Petrilla1, Gábor Mátis1, Máté Mackei1, Anna Kulcsár1, Csilla Sebők1, Márton Papp2, Péter Gálfi3, Hedvig Fébel4, Korinna Huber5, Zsuzsanna Neogrády1.
Abstract
Influencing the endocrine metabolic regulation of chickens by nutritional factors might provide novel possibilities for improving animal health and productivity. This study was designed to evaluate the impact of dietary cereal type (wheat-based (WB) vs. maize-based (MB) diets), crude protein level (normal (NP) vs. lowered (LP)), and sodium (n-)butyrate (1.5 g/kg diet) supplementation (vs. no butyrate) on the responsiveness of hepatic glucagon receptor (GCGR), insulin receptor beta (IRβ) and mammalian target of rapamycin (mTOR) in the phase of intensive growth of chickens. Liver samples of Ross 308 broiler chickens (Gallus gallus domesticus) were collected on day 21 for quantitative real-time polymerase chain reaction and Western blot analyses. Hepatic GCGR and mTOR gene expressions were up-regulated by WB and LP diet. GCGR and IRβ protein level decreased in groups with butyrate supplementation; however, the quantity of IRβ and mTOR protein increased in WB groups. Based on these data, the applied dietary strategies may be useful tools to modulate hepatic insulin and glucagon signaling of chickens in the period of intensive growth. The obtained results might contribute to the better understanding of glycemic control of birds and increase the opportunity of ameliorating insulin sensitivity, hence, improving the production parameters and the welfare of broilers.Entities:
Keywords: butyrate; chicken; glucagon; hepatic glucagon receptor; insulin; insulin receptor beta; mammalian target of rapamycin; non-starch polysaccharides
Year: 2022 PMID: 35324832 PMCID: PMC8955576 DOI: 10.3390/vetsci9030103
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Ingredients and calculated nutrient composition of experimental broiler starter diets without sodium butyrate supplementation.
| Ingredients | Unit | Maize-Based | Maize-Based | Wheat-Based | Wheat-Based |
|---|---|---|---|---|---|
| Maize | % | 57.60 | 61.00 | 0 | 0 |
| Wheat | % | 0 | 0 | 54.79 | 62.60 |
| Solvent extr. soybean meal | % | 27.00 | 28.00 | 31.00 | 26.48 |
| PL-68 † | % | 6.50 | 0 | 3.00 | 0 |
| Sunflower oil | % | 3.50 | 3.50 | 6.00 | 5.30 |
| Wheat bran | % | 0 | 1.72 | 0 | 0 |
| Limestone | % | 1.70 | 1.60 | 1.70 | 1.70 |
| MCP | % | 1.80 | 2.00 | 1.70 | 1.70 |
| Salt (NaCl) | % | 0.40 | 0.40 | 0.40 | 0.40 |
| L-lysine hydrochloride | % | 0.44 | 0.58 | 0.38 | 0.60 |
| DL-methionine | % | 0.43 | 0.44 | 0.41 | 0.45 |
| L-threonine | % | 0.09 | 0.22 | 0.11 | 0.26 |
| L-tryptophan | % | 0.04 | 0.04 | 0 | 0 |
| Vitamin and mineral premix ‡ | % | 0.50 | 0.50 | 0.50 | 0.50 |
| Axtra XB 201 enzyme § | % | 0.015 | 0.015 | ||
| Calculated values | |||||
| Dry matter | % | 89.65 | 89.32 | 89.78 | 89.47 |
| Crude protein | % | 22.02 | 18.65 | 22.05 | 18.76 |
| Soluble NSP | Mg/kg | 506.88 | 536.80 | 5133.82 | 5865.62 |
| ME | MJ/kg | 12.65 | 12.61 | 12.63 | 12.62 |
| Ether extract | % | 6.54 | 6.30 | 7.49 | 6.62 |
| Crude fiber | % | 2.51 | 2.74 | 2.88 | 2.81 |
| Ash | % | 6.97 | 7.23 | 7.37 | 7.42 |
| Lysine | % | 1.43 | 1.43 | 1.44 | 1.43 |
| Methionine + Cystine | % | 1.07 | 1.05 | 1.08 | 1.07 |
| Threonine | % | 0.97 | 0.94 | 0.94 | 0.94 |
| Tryptophan | % | 0.23 | 0.25 | 0.26 | 0.24 |
| Arginine | % | 1.17 | 1.24 | 1.34 | 1.22 |
| Isoleucine | % | 0.74 | 0.78 | 0.85 | 0.78 |
| Leucine | % | 1.59 | 1.68 | 1.52 | 1.41 |
| Valine | % | 0.83 | 0.88 | 0.93 | 0.86 |
| Total Ca | % | 1.15 | 1.15 | 1.16 | 1.14 |
| Total P | % | 0.79 | 0.80 | 0.82 | 0.80 |
| Available P | % | 0.54 | 0.53 | 0.56 | 0.54 |
CP: crude protein; MCP: monocalcium phosphate; ME: metabolizable energy; NSP: soluble non-starch polysaccharide. † Protein concentrate, by-product of glutamic acid production from bacterial biomass (KJK-Agroteam Ltd., Dombóvár, Hungary). ‡ Provides per kilogram of diet: vitamin A 12,013 IU; vitamin D3 3875 IU; vitamin K 3.3 mg; vitamin E 46.5 IU; vitamin B1 2.33 mg; vitamin B2 7.44 mg; vitamin B6 3.88 mg, vitamin B12 0.016 mg; calcium pantothenate 13.95 mg; folic acid 1.56 mg; niacin 46.5 mg; choline chloride 504 mg; Fe 60 mg; Mn 100 mg; Cu 12.5 mg; Zn 83 mg; Se 0.42 mg; Co 0.28 mg; I 1.25 mg. § Enzymatic activity in the product (DuPont Animal Nutrition, New Century, KS, USA) 12,200 U/g endo-1,4-beta-xylanase and 1520 U/g endo-1,3(4)-beta-glucanase.
Ingredients and calculated nutrient composition of experimental broiler grower diets without sodium butyrate supplementation.
| Ingredients | Unit | Maize-Based | Maize-Based | Wheat-Based | Wheat-Based |
|---|---|---|---|---|---|
| Maize | % | 60.71 | 65.31 | 0 | 0 |
| Wheat | % | 0 | 0 | 61.30 | 66.56 |
| Solvent extr. soybean meal | % | 22.20 | 24.54 | 19.31 | 20.01 |
| PL-68 † | % | 8.00 | 1.00 | 8.50 | 2.50 |
| Sunflower oil | % | 4.80 | 4.50 | 6.70 | 6.50 |
| Wheat bran | % | 0 | 0 | 0 | 0 |
| Limestone | % | 1.30 | 1.20 | 1.35 | 1.35 |
| MCP | % | 1.35 | 1.60 | 1.15 | 1.15 |
| Salt (NaCl) | % | 0.40 | 0.40 | 0.40 | 0.40 |
| L-lysine hydrochloride | % | 0.34 | 0.41 | 0.38 | 0.48 |
| DL-methionine | % | 0.36 | 0.37 | 0.35 | 0.38 |
| L-threonine | % | 0 | 0.15 | 0.05 | 0.16 |
| L-tryptophan | % | 0.04 | 0.02 | 0 | 0 |
| Vitamin and mineral premix ‡ | % | 0.50 | 0.50 | 0.50 | 0.50 |
| Axtra XB 201 enzyme § | % | 0,015 | 0,015 | ||
| Calculated values | |||||
| Dry matter | % | 89.72 | 89.34 | 89.90 | 89.55 |
| Crude protein | % | 21.12 | 17.85 | 21.10 | 17.89 |
| Soluble NSP | Mg/kg | 534.25 | 574.73 | 5743.81 | 6236.67 |
| ME | MJ/kg | 13.27 | 13.24 | 13.24 | 13.24 |
| Ether extract | % | 7.96 | 7.39 | 8.45 | 7.92 |
| Crude fiber | % | 2.34 | 2.48 | 2.51 | 2.61 |
| Ash | % | 5.78 | 6.03 | 6.00 | 6.13 |
| Lysine | % | 1.25 | 1.22 | 1.25 | 1.22 |
| Methionine + Cystine | % | 0.96 | 0.95 | 0.94 | 0.95 |
| Threonine | % | 0.84 | 0.84 | 0.85 | 0.81 |
| Tryptophan | % | 0.21 | 0.20 | 0.20 | 0.21 |
| Arginine | % | 1.01 | 1.11 | 0.97 | 1.02 |
| Isoleucine | % | 0.65 | 0.72 | 0.62 | 0.65 |
| Leucine | % | 1.45 | 1.58 | 1.14 | 1.20 |
| Valine | % | 0.74 | 0.81 | 0.70 | 0.74 |
| Total Ca | % | 0.92 | 0.93 | 0.90 | 0.90 |
| Total P | % | 0.68 | 0.69 | 0.71 | 0.67 |
| Available P | % | 0.45 | 0.45 | 0.49 | 0.44 |
CP: crude protein; MCP: monocalcium phosphate; ME: metabolizable energy; NSP: soluble non-starch polysaccharide. † Protein concentrate, by-product of glutamic acid production from bacterial biomass (KJK-Agroteam Ltd., Dombóvár, Hungary). ‡ Provides per kilogram of diet: vitamin A 12,013 IU; vitamin D3 3875 IU; vitamin K 3.3 mg; vitamin E 46.5 IU; vitamin B1 2.33 mg; vitamin B2 7.44 mg; vitamin B6 3.88 mg, vitamin B12 0.016 mg; calcium pantothenate 13.95 mg; folic acid 1.56 mg; niacin 46.5 mg; choline chloride 504 mg; Fe 60 mg; Mn 100 mg; Cu 12.5 mg; Zn 83 mg; Se 0.42 mg; Co 0.28 mg; I 1.25 mg. § 1Enzymatic activity in the product (DuPont Animal Nutrition, New Century, KS, USA) 12,200 U/g endo-1,4-beta-xylanase and 1520 U/g endo-1,3(4)-beta-glucanase.
Primer pairs used to test genes of interest.
| Gene | Primer | Primer Sequence | Amplicon Size | NCBI Accession | Threshold |
|---|---|---|---|---|---|
| GAPDH | Forward (5′-3′) | GGGCACGCCATCACTATCTT | 187 | NM204305.1 | 0.03 |
| Reverse (5′-3′) | TCACAAACATGGGGGCATCA | ||||
| GCGR | Forward (5′-3′) | ATCCCGTGGGTTGTTGTGAA | 195 | NM001101035.1 | 0.02 |
| Reverse (5′-3′) | CTTGTAGTCGGTGTAGCGCA | ||||
| IRβ | Forward (5′-3′) | CAACCCACACTGGTGGTCAT | 134 | XM 001233398.5 | 0.0036 |
| Reverse (5′-3′) | GCAGCCATCTGGATCATTTCTC | ||||
| mTOR | Forward (5′-3′) | GTGGCGATCCTATGGCATGA | 276 | XM417614.6 | 0.05 |
| Reverse (5′-3′) | ACGCCTGAAAACGTGGTAGT |
GAPDH: glyceraldehyde-3-phosphate dehydrogenase (housekeeping gene); GCGR: glucagon receptor; IRβ: insulin receptor β; mTOR: mammalian target of rapamycin. Threshold was calculated by software.
Figure 1Relative gene expression (A) and protein abundance (B) of hepatic glucagon receptor. MB: maize-based diet; WB: wheat-based diet supplemented with NSP-degrading xylanase and glucanase enzymes; NP: “Normal protein” group reared on a diet with crude protein content adequate to the dietary phase; LP: “Low protein” group reared on a diet with crude protein content reduced by 15%, supplemented with limiting amino acids; But: sodium butyrate supplementation of the diet in the dose of 1.5 g/kg diet; Ctr: control group without sodium butyrate supplementation. Letters indicate groups that were significantly different with pairwise comparison. If two groups have different letters, p-values were <0.05.
Figure 2Relative gene expression (A) and protein abundance (B) of hepatic insulin receptor β. MB: maize based diet; WB: wheat based diet supplemented with NSP-degrading xylanase and glucanase enzymes; NP: “Normal protein” group reared on a diet with crude protein content adequate to the dietary phase; LP: “Low protein” group reared on a diet with crude protein content reduced by 15%, supplemented with limiting amino acids; But: sodium butyrate supplementation of the diet in the dose of 1.5 g/kg diet; Ctr: control group without sodium butyrate supplementation. Letters indicate groups that were significantly different with pairwise comparison. If two groups have different letters, p-values were <0.05.
Figure 3Relative gene expression (A) and protein abundance (B) of hepatic mammalian target of rapamycin. MB: maize-based diet; WB: wheat-based diet supplemented with NSP-degrading xylanase and glucanase enzymes; NP: “Normal protein” group reared on a diet with crude protein content adequate to the dietary phase; LP: “Low protein” group reared on a diet with crude protein content reduced by 15%, supplemented with limiting amino acids; But: sodium butyrate supplementation of the diet in the dose of 1.5 g/kg diet; Ctr: control group without sodium butyrate supplementation. Letters indicate groups that were significantly different with pairwise comparison. If two groups have different letters, p-values were <0.05.
Representative bands corresponding to the investigated proteins, as obtained by Western blotting.
| Parameter | MB NP Ctr | MB NP But | MB LP Ctr | MB LP But | WB NP Ctr | WB NP But | WB LP Ctr | WB LP But |
|---|---|---|---|---|---|---|---|---|
| GR |
|
|
|
|
|
|
|
|
| IRβ |
|
|
|
|
|
|
|
|
| mTOR |
|
|
|
|
|
|
|
|
GCGR: glucagon receptor (57 kDal); IRβ: insulin receptor β (95 kDal); mTOR: mammalian target of rapamycin (289 kDal). MB: maize-based diet; WB: wheat-based diet supplemented with NSP-degrading xylanase and glucanase enzymes; NP: “Normal protein” group reared on a diet with crude protein content adequate to the dietary phase; LP: “Low protein” group reared on a diet with crude protein content reduced by 15%, supplemented with limiting amino acids; But: sodium butyrate supplementation of the diet in the dose of 1.5 g/kg diet; Ctr: control group without sodium butyrate supplementation. Western blot Original Images in file S1.
Figure 4Overview of the insulin and glucagon signaling pathways and the observed main effects of the investigated nutritional factors. IRα: insulin receptor α subunit; IRβ: insulin receptor β subunit; IRS-1: insulin receptor substrate 1 (“a” lowercase subscript when activated); PI3K: phosphatidylinositol-3-kinase (“a” lowercase subscript when activated); PIP2: phosphatidylinositol diphosphate; PIP3: phosphatidylinositol triphosphate; PKB: protein kinase B; mTOR: mammalian target of rapamycin; Ca2+: calcium ion; cAMP: cyclic adenosine monophosphate; PKC: protein kinase C; PKA: protein kinase A; P: phosphate group; MB: maize-based diet; WB: wheat-based diet supplemented with NSP-degrading xylanase and glucanase enzymes; NP: “Normal protein” group reared on a diet with crude protein content adequate to the dietary phase; LP: “Low protein” group reared on a diet with crude protein content reduced by 15%, supplemented with limiting amino acids; But: sodium butyrate supplementation of the diet in the dose of 1.5 g/kg diet. ↓ and ↑ arrows indicate the lowering or increasing effect of the given nutritional factor on the investigated parameter.